Select Page
Responsive Centered YouTube Video
Geert's warning about mass vaccination during a pandemic and the consequences of silencing critical voices
  • Geert’s extensive background in virology and vaccine development. 1:32

  • His concerns about mass vaccination during a pandemic. 3:00

  • Examples of past vaccination campaigns leading to detrimental consequences. 7:01

  • Criticism of global health organizations for silencing critical voices. 8:33

Geert expresses concerns about the impact of mass vaccination on the generation of immune escape variants and the future consequences for the healthcare system
  • Geert criticizes the vaccine industry’s focus on profit over public health. 10:04

  • He emphasizes the importance of preventing infection in a global health context to fight a pandemic. 13:23

  • Geert warns about the self-perpetuating cycle of immune escape variant generation due to mass vaccination. 14:34

  • He highlights the short-sightedness of politicians and public health authorities in addressing the disastrous consequences for the healthcare system. 15:42

Concerns about the impact of highly vaccinated populations on the spread of new Covid variants and the effectiveness of the vaccine
  • Highly vaccinated populations are unable to stop the virus from circulating, leading to a continuous cycle of variants. 16:32

  • The virus continues to evolve, preventing the development of herd immunity and leading to breakthrough infections. 17:03

  • The current approach to control the virus has not been effective, and the situation is not sustainable. 18:17

  • The vaccine’s inability to control the virus and its impact on immune responses raise questions about its classification as a traditional vaccine. 20:07

  • The vaccine induces immune refocusing, leading to a chain of irreversible consequences. 24:09

Concerns about immune escape due to vaccine-induced antibodies targeting less immunogenic epitopes, leading to suboptimal neutralization and promoting more infectious variants
  • Vaccine-induced antibodies refocus immune response to less immunogenic epitopes. 24:29

  • Vaccine breakthrough infections boost previously induced antibodies to high titer. 26:05

  • Boosted antibodies recognize subdominant epitopes, inducing cross neutralizing antibodies. 27:50

  • Cross neutralizing antibodies exert suboptimal immune pressure, promoting more infectious variants. 29:39

  • mRNA vaccines induce low affinity antibodies targeting less immunogenic epitopes. 30:38

  • Manufacturers overlooked the generation of low affinity antibodies in mRNA vaccines. 32:15

  • Only a small proportion of antibodies target the new variant ba286. 32:48

Concerns about the impact of new Covid variant on immune response and vaccine efficacy
  • The primary immune response is not improving, indicating a serious situation. 32:57

  • Administering vaccines or booster doses may accelerate immune escape. 33:58

  • Low affinity antibodies only interact with multimeric virus presentation, leading to pseudo neutralization. 34:52

  • Antibodies with diminished neutralizing capacity can enhance infection by masking immunogenic epitopes. 39:04

  • Recognition of previously non-immunogenic epitopes can lead to the production of non-neutralizing antibodies. 40:20

  • The conserved antigenic site within the Spike protein can be targeted by the immune system, leading to enhanced infection. 40:46

Concerns about the impact of new Covid variant mutations on vaccine effectiveness and viral evolution
  • Low affinity antibodies stabilize viral aggregates, promoting immune evasion. 41:08

  • Evolution of gn1 variant indicates significant immune pressure and ongoing viral evolution. 46:07

  • Ba2.86 mutations show continuous evolution of the virus. 48:07

Concerns about the new Covid variant and its implications on immune response and infection mitigation
  • The new variant, gn1, is spreading rapidly and outpacing other variants globally. 52:01

  • There is a surge in hospitalization, severe disease, and death related to the new variant. 52:23

  • Mutations in gn1 are not limited to conserved domains and are uncommon, rare, and not spike-specific. 52:53

  • These mutations have an infection-enhancing effect, promoting viral protein synthesis and intracellular replication. 53:50

  • The immune pressure on the virus has moved away from targeting common epitopes and even epitopes within Spike. 54:53

  • The observation suggests that the infection mitigation is now driven by cytotoxic T cells (CTLs). 56:03

  • There is a shift towards CTLs targeting a universal epitope shared among coronaviruses, not specific to Spike. 56:28

  • The theory indicates a potential stage where CTLs take over in mitigating the infection. 57:18

Analysis of the impact of new Covid variant on immune response and vaccination efficacy
  • CTLS cannot prevent infection due to lack of memory. 57:49

  • New variant mutations target universal epitopes, affecting immune response. 58:41

  • Shift from antibody to cell-mediated immune response observed. 59:37

  • Antigen presenting cells overwhelmed by larger aggregates, impacting vaccine efficacy. 1:01:02

  • Diminishing concentration of infection-enhancing antibodies poses a disaster. 1:05:10

Concerns about the impact of the new Covid variant on vaccinated and unvaccinated individuals, including immune system training and potential asymptomatic infections
  • Antibodies with weak affinity can block trans infection, affecting virus transfer to susceptible cells in organs. 1:05:43

  • CTL-mediated mitigation of infection can diminish concentration of infection-enhancing antibodies. 1:06:14

  • Immunological pressure on virus virulence may lead to fitness cost and reduced infectiousness. 1:06:43

  • Unvaccinated individuals rely on trained innate immune system, while vaccinated individuals may have a corrupted adaptive immune system. 1:08:19

  • Viral circulation poses a risk of recurring infection for both vaccinated and unvaccinated individuals. 1:11:44

  • Epigenetic changes impact the functionality of innate immune cells, similar to physical training. 1:12:43

Warning about the impact of the new Covid variant and concerns about its evolution and vaccine effectiveness
  • Observation of the Covid crisis as a fight between stakeholders and underdogs. 1:13:16

  • Importance of innate immunity in dealing with variants. 1:14:06

  • Focus on debates and lawsuits rather than virus evolution. 1:15:11

  • Prediction of tremendous losses due to the new variant. 1:20:09

Warning about the emergence of a highly infectious and potentially virulent new Covid variant, with concerns about the effectiveness of current vaccines and public health strategies
  • Warning about the emergence of a highly infectious new variant. 1:20:15

  • Shift in reliance from antibodies to CTLS for infection mitigation. 1:21:22

  • Criticism of public health authorities’ messaging and strategies. 1:24:19

  • Prediction of rapid evolution and impact of the new variant. 1:24:31

  • Emphasis on the urgency of the situation and need for immediate action. 1:24:41

  • Assertion that the current situation renders previous discussions obsolete. 1:24:50

  • Call for scientists to verify neutralizing antibody effectiveness. 1:25:35

  • Concerns about the potential virulence in highly vaccinated populations. 1:27:14

  • Prediction of exponential increase in mortality and morbidity rates. 1:27:32

Urgent warning about the new Covid variant and the need for action to suppress its spread
  • Vaccinated individuals at risk of increased mortality and morbidity. 1:27:40

  • Urgent recommendation for thorough vaccination and antivirus usage. 1:28:15

  • Prediction of exponential growth in virus spread. 1:28:25

  • Anticipation of mandates for antivirus usage. 1:28:40

  • Acknowledgment of monumental crisis and potential window of opportunity for suppression. 1:29:31

  • Importance of taking action to mitigate the disaster. 1:30:08

  • Expression of disbelief at the scale of the disaster. 1:30:45

  • Emphasis on thorough research and conviction in the presented analysis. 1:31:20

  • Comparison of situation to predicting a volcano eruption based on surface vs. underground analysis. 1:33:26

Geert expresses genuine concern for humanity and willingness to stand up, despite potential criticism
  • Geert speaks from the heart and has genuine conviction. 1:34:42

  • He is willing to make his voice heard despite potential criticism. 1:34:51

  • Acknowledgement of the difficult message being shared. 1:35:33